Home › Hemophilia B › Tennessee
Hemophilia B clinical trials in Tennessee
4 studies for Hemophilia B are looking for participants at sites in Tennessee.
Cities in Tennessee
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 3
138 Months – 206 Months · Men · Updated Sep 16, 2026 · NCT07080905A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 1/2
Ages 2 and older · Men · Updated Sep 11, 2026 · NCT06379789ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- St. Jude Children's Research Hospital, Memphis
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 4
Ages 12 to 100 · All sexes · Updated Jan 12, 2026 · NCT04647227From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.